Reactive oxygen species-dependent TNF-α converting enzyme activation through stimulation of 5-HT2B and α1D autoreceptors in neuronal cells

FASEB Journal

Volumn 19, Issue 9, 2005, Pages 1078-1087

  Pietri, Mathéa ^a   Schneider, Benoît ^a,d   Mouillet Richard, Sophie ^a   Ermonval, Myriam ^a   Mutel, Vincent ^b   Launay, Jean Marie ^c   Kellermann, Odile ^a  

^a INSTITUT ANDRÉ LWOFF   (France)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c HÔPITAL LARIBOISIÈRE   (France)

^d CNRS   (France)

Author keywords

Bioaminergic autoreceptors; Metalloproteinase; Neuronal differentiation; Neuronal homeostasis; ROS signaling

Indexed keywords

ADRENERGIC RECEPTOR; AUTORECEPTOR; DISINTEGRIN; METALLOPROTEINASE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SEROTONIN 1A RECEPTOR; SEROTONIN 2B RECEPTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVATION; HOMEOSTASIS; MOUSE; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC NERVE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PERIKARYON; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION; UPREGULATION;

ADAM PROTEINS; ANIMALS; AUTORECEPTORS; CELL DIFFERENTIATION; CELL LINE; ENZYME ACTIVATION; HOMEOSTASIS; MICE; NADPH OXIDASE; NEURODEGENERATIVE DISEASES; NEURONS; REACTIVE OXYGEN SPECIES; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTOR, SEROTONIN, 5-HT2B; SIGNAL TRANSDUCTION;

EID: 21744435912     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-3631com     Document Type: Article

References (51)

1. Mattson, M. P., and Sherman, M. (2003) Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation. Neuromol. Med. 4, 109-132
2. Friedman, J. I., Adler, D. N., and Davis, K. L. (1999) The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol. Psychiatry 46, 1243-1252
3. Barnham, K. J., Masters, C. L., and Bush, A. I. (2004) Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205-214
4. Andersen, J. K. (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10, S18-S25
5. Kamata, H., and Hirata, H. (1999) Redox regulation of cellular signalling. Cell. Signal. 11, 1-14
6. Thannickal, V. J., and Fanburg, B. L. (2000) Reactive oxygen species in cell signaling. Am. J. Physiol. 279, L1005-L1028
7. Lee, S. L., Wang, W. W., Lanzillo, J. J., and Fanburg, B. L. (1994) Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am. J. Physiol. 266, L46-L52
8. Lee, S. L., Simon, A. R., Wang, W. W., and Fanburg, B. L. (2001) H(2)O(2) signals 5-HT-induced ERK MAP kinase activation and mitogenesis of smooth muscle cells. Am. J. Physiol. 281, L646-L652
9. Jaffre, F., Callebert, J., Sarre, A., Etienne, N., Nebigil, C. G., Launay, J. M., Maroteaux, L., and Monassier, L. (2004) Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-α cytokine production by ventricular fibroblasts. Circulation 110, 969-974
10. Amin, J. K., Xiao, L., Pimental, D. R., Pagano, P. J., Singh, K., Sawyer, D. B., and Colucci, W. S. (2001) Reactive oxygen species mediate α-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 33, 131-139
11. Xiao, L., Pimentel, D. R., Wang, J., Singh, K., Colucci, W. S., and Sawyer, D. B. (2002) Role of reactive oxygen species and NAD(P)H oxidase in α (1)-adrenoceptor signaling in adult rat cardiac myocytes. Am. J. Physiol. 282, C926-C934
12. Hoyer, D., Hannon, J. P., and Martin, G. R. (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71, 533-554
13. Gaspar, P., Cases, O., and Maroteaux, L. (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 4, 1002-1012
14. Philipp, M., and Hein, L. (2004) Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol. Ther. 101, 65-74
15. Mouillet-Richard, S., Mutel, V., Loric, S., Tournois, C., Launay, J. M., and Kellermann, O. (2000) Regulation by neurotransmitter receptors of serotonergic or catecholaminergic neuronal cell differentiation. J. Biol. Chem. 275, 9186-9192
16. Kellermann, O., Loric, S., Maroteaux, L., and Launay, J. M. (1996) Sequential onset of three 5-HT receptors during the 5-hydroxytryptaminergic differentiation of the murine 1C11 cell line. Br. J. Pharmacol. 118, 1161-1170
17. Porter, R. H., Benwell, K. R., Lamb, H., Malcolm, C. S., Allen, N. H., Revell, D. F., Adams, D. R., and Sheardown, M. J. (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br. J. Pharmacol. 128, 13-20
18. Cussac, D., Newman-Tancredi, A., Quentric, Y., Carpentier, N., Poissonnet, G., Parmentier, J. G., Goldstein, S., and Millan, M. J. (2002) Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols. Naunyn Schmiedebergs Arch. Pharmacol. 365, 242-252
19. Jerman, J. C., Brough, S. J., Gager, T., Wood, M., Coldwell, M. C., Smart, D., and Middlemiss, D. N. (2001) Pharmacological characterisation of human 5-HT2 receptor subtypes. Eur. J. Pharmacol. 414, 23-30
20. Audia, J. E., Evrard, D. A., Murdoch, G. R., Droste, J. J., Nissen, J. S., Schenck, K. W., Fludzinski, P., Lucaites, V. L., Nelson, D. L., and Cohen, M. L. (1996) Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus. J. Med. Chem. 39, 2773-2780
21. Schneider, B., Mutel, V., Pietri, M., Ermonval, M., Mouillet-Richard, S., and Kellermann, O. (2003) NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA 100, 13326-13331
22. Manivet, P., Mouillet-Richard, S., Callebert, J., Nebigil, C. G., Maroteaux, L., Hosoda, S., Kellermann, O., and Launay, J. M. (2000) PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor. J. Biol. Chem. 275, 9324-9331
23. Loric, S., Maroteaux, L., Kellermann, O., and Launay, J. M. (1995) Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation. Mol. Pharmacol. 47, 458-466
24. Quinn, M. T., Evans, T., Loetterle, L. R., Jesaitis, A. J., and Bokoch, G. M. (1993) Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J. Biol. Chem. 268, 20983-20987
25. 2+-depleted human neutrophils. Biochem. J. 290, 173-178
26. Kawakami, N., Kita, K., Hayakawa, T., Yamaguchi, T., and Fujimoto, S. (2000) Phorbol myristate acetate induces NADPH oxidase activity of cytochalasin B-primed neutrophils through the protein kinase C-independent pathway. Biol. Pharm. Bull. 23, 1100-1104
27. Zhang, Z., Oliver, P., Lancaster, J. J., Schwarzenberger, P. O., Joshi, M. S., Cork, J., and Kolls, J. K. (2001) Reactive oxygen species mediate tumor necrosis factor α-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 15, 303-305
28. Black, R. A. (2002) Tumor necrosis factor-α converting enzyme. Int. J. Biochem. Cell Biol. 34, 1-5
29. Choi, D. S., and Maroteaux, L. (1996) Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain. FEBS Lett. 391, 45-51
30. Duxon, M. S., Flanigan, T. P., Reavley, A. C., Baxter, G. S., Blackburn, T. P., and Fone, K. C. (1997) Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 76, 323-329
31. Volgin, D. V., Mackiewicz, M., and Kubin, L. (2001) Alpha(1B) receptors are the main postsynaptic mediators of adrenergic excitation in brainstem motoneurons, a single-cell RT-PCR study. J. Chem. Neuroanat. 22, 157-166
32. Osborne, P. B., Vidovic, M., Chieng, B., Hill, C. E., and Christie, M. J. (2002) Expression of mRNA and functional α (1)-adrenoceptors that suppress the GIRK conductance in adult rat locus coeruleus neurons. Br. J. Pharmacol. 135, 226-232
33. Goridis, C., and Rohrer, H. (2002) Specification of catecholaminergic and serotonergic neurons. Nat. Rev. Neurosci. 3, 531-541
34. Tournois, C., Mutel, V., Manivet, P., Launay, J. M., and Kellermann, O. (1998) Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism. J. Biol. Chem. 273, 17498-17503
35. Brown, D. A., and London, E. (1998) Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111-136
36. Alonso, M. A., and Millan, J. (2001) The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J. Cell Sci. 114, 3957-3965
37. Anderson, R. G., and Jacobson, K. (2002) A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296, 1821-1825
38. Vilhardt, F., and Van Deurs, B. (2004) The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J. 23, 739-748
39. Baud, V., and Karin, M. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377
40. MacEwan, D. J. (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell. Signal. 14, 477-492
41. Gaur, U., and Aggarwal, B. B. (2003) Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem. Pharmacol. 66, 1403-1408
42. Merrill, J. E. (1992) Tumor necrosis factor α, interleukin 1 and related cytokines in brain development: normal and pathological. Dev. Neurosci. 14, 1-10
43. Tamatani, M., Che, Y. H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., Mizuno, T., and Tohyama, M. (1999) Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274, 8531-8538
44. Ignatowski, T. A., Noble, B. K., Wright, J. R., Gorfien, J. L., Heffner, R. R., and Spengler, R. N. (1997) Neuronal-associated tumor necrosis factor (TNF α): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J. Neuroimmunol. 79, 84-90
45. Hayley, S., Brebner, K., Lacosta, S., Merali, Z., and Anisman, H. (1999) Sensitization to the effects of tumor necrosis factor-α: neuroendocrine, central monoamine, and behavioral variations. J. Neurosci. 19, 5654-5665
46. Scherzer, J. A., Lin, Y., McLeish, K. R., and Klein, J. B. (1997) TNF translationally modulates the expression of G1 protein α (i2) subunits in human polymorphonuclear leukocytes. J. Immunol. 158, 913-918
47. Higuchi, M., and Aggarwal, B. B. (1994) TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J. Immunol. 152, 3550-3558
48. Kordek, R., Nerurkar, V. R., Liberski, P. P., Isaacson, S., Yanagihara, R., and Gajdusek, D. C. (1996) Heightened expression of tumor necrosis factor a, interleukin 1 α, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl. Acad. Sci. USA 93, 9754-9758
49. Williams, A., Van Dam, A. M., Ritchie, D., Eikelenboom, P., and Fraser, H. (1997) Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res, 754, 171-180
50. Viviani, B., Bartesaghi, S., Corsini, E., Galli, C. L., and Marinovich, M. (2004) Cytokines role in neurodegenerative events. Toxicol. Lett. 149, 85-89
51. Mhatre, M., Floyd, R. A., and Hensley, K. (2004) Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J. Alzheimers Dis. 6, 147-157